Skip to content

World Health Organization WHO Finds No Abuse Potential or Public Health Risks from CBD Oil Use and Potential Therapeutic Benefits

The World Health Organization WHO finds no abuse potential or public health risks from CBD oil use and potential therapeutic benefits.

The Expert Committee on Drug Dependence met in Geneva, Switzerland for its 39th annual meeting on 6-10 November 2017.

During the meeting the committee reported that not only did they find no abuse potential or public health risks from using CBD oil, but also that people suffering from many diseases may have therapeutic benefits from taking CBD oil.

CANNABIDIOL (CBD) Pre-Review Report Summary

The entire report can be seen by clicking here.

Cannabidiol (CBD) is one of the naturally occurring cannabinoids found in cannabis plants. It
is a 21-carbon terpenophenolic compound which is formed following decarboxylation from a
cannabidiolic acid precursor, although it can also be produced synthetically.
CBD can be converted to tetrahydrocannabinol (THC) under experimental conditions;
however, this does not appear to occur to any significant effect in patients undergoing CBD
treatment.

In experimental models of abuse liability, CBD appears to have little effect on conditioned
place preference or intracranial self-stimulation. In an animal drug discrimination model CBD
failed to substitute for THC. In humans, CBD exhibits no effects indicative of any abuse or
dependence potential.

CBD has been demonstrated as an effective treatment of epilepsy in several clinical trials, with
one pure CBD product (Epidiolex®) currently in Phase III trials. There is also preliminary
evidence that CBD may be a useful treatment for a number of other medical conditions.
There is unsanctioned medical use of CBD based products with oils, supplements, gums, and
high concentration extracts available online for the treatment of many ailments.

CBD is generally well tolerated with a good safety profile. Reported adverse effects may be as
a result of drug-drug interactions between CBD and patients’ existing medications.
Several countries have modified their national controls to accommodate CBD as a medicinal
product.

To date, there is no evidence of recreational use of CBD or any public health related problems
associated with the use of pure CBD.

Therapeutic Applications and Extent of Therapeutic Use and Epidemiology of Medical Use

Epilepsy

The clinical use of CBD is most advanced in the treatment of epilepsy. In clinical trials, CBD has been demonstrated as an effective treatment for at least some forms of epilepsy, with one pure CBD product (Epidiolex®) currently in Phase III trials.

Overview of diseases for which CBD may have therapeutic benefits

The World Health Organizations report shows promise of therapeutic benefits of CBD oil with no potential abuse or public health risks. The good news is you can have CBD Oil delivered to your door by ordering from HempWorxBayCity.com by clicking here.